Volume 194, Issue 5 , Pages 1411-1417, May 2006
Effect of patient age on increasing morbidity and mortality following urogynecologic surgery
Objective
The purpose of this study was to estimate the effect of age on the risk of in-hospital mortality and morbidity following urogynecologic surgery and to compare risks associated with obliterative versus reconstructive procedures for prolapse in elderly women.
Study design
We conducted a retrospective cohort study utilizing data from 1998 to 2002 from the Nationwide Inpatient Sample. Multivariable logistic regression was performed to obtain odds ratios estimating the effect of age on risk of death and complications, adjusting for comorbidities and demographic factors.
Results
There were 264,340 women in our study population. Increasing age was associated with higher mortality risks per 1000 women (<60 years, 0.1; 60-69 years, 0.5; 70-79 years, 0.9; ≥80 years, 2.8; P < .01) and higher complication risks per 1000 women (<60 years, 140; 60-69 years, 130; 70-79 years, 160; ≥80 years, 200; P < .01). Using multivariable logistic regression, increasing age was associated with an increased risk of death (60-69 years, odds ratio [OR] 3.4 [95% CI 1.7-6.9]; 70-79 years, OR 4.9 [95% CI 2.2-10.9]; ≥80 years, OR 13.6 [95% CI 5.9-31.4]), compared with women <60 years. The risk of peri-operative complications was also higher in elderly women 80 years of age and older (OR 1.4 [95% CI 1.3-1.5]) compared with younger women. Elderly women 80 years and over who underwent obliterative procedures had a lower risk of complication compared with those who underwent reconstructive procedures for prolapse (17.0% vs 24.7%, P < .01).
Conclusion
Although the absolute risk of death is low, elderly women have a higher risk of mortality and morbidity following urogynecologic surgery.
Key words: Urogynecologic surgery, Pelvic floor disorders, Elderly, Morbidity, Mortality
To access this article, please choose from the options below
Supported in part by grant T32: HD040674-03; WIH/Brown Epidemiology/Clinical Trials Training Program; National Institute of Child Health and Human Development.Presented at the Twenty-Sixth Annual Meeting of the American Urogynecologic Society, Atlanta, GA, September 15-17, 2005.Reprints not available from the authors.
PII: S0002-9378(06)00091-3
doi:10.1016/j.ajog.2006.01.050
© 2006 Mosby, Inc. All rights reserved.
Volume 194, Issue 5 , Pages 1411-1417, May 2006
